Serum KL-6 level is increased in patients with pneumocystis pneumonia
S. Hirata, A. Yokoyama, H. Ohnishi, Y. Haruta, N. Ishikawa, K. Fujitaka, Y. Taooka, N. Hattori, H. Hamada, K. Nishimura, N. Kohno (Hiroshima, Toon, Japan; Denver, United States Of America)
Source: Annual Congress 2006 - Clinical management of interstitial lung disease
Session: Clinical management of interstitial lung disease
Session type: E-Posters in free access
Number: 668
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hirata, A. Yokoyama, H. Ohnishi, Y. Haruta, N. Ishikawa, K. Fujitaka, Y. Taooka, N. Hattori, H. Hamada, K. Nishimura, N. Kohno (Hiroshima, Toon, Japan; Denver, United States Of America). Serum KL-6 level is increased in patients with pneumocystis pneumonia. Eur Respir J 2006; 28: Suppl. 50, 668
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Serum indicators for the diagnosis of pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 559s Year: 2006
Serum levels of IL-6 in severe community-acquired pneumonia Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010
Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003
Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis. Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019
Elevated levels of serum SP-A in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Elevated troponin and creatinine levels are associated with higher mortality in community-acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010
Admission CRP and D-dimer levels can identify high-risk patients with community-acquired pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Serum procalcitonin and C-reactive protein in children with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006
Elevated levels of BALF galectin-9 in patients with interstitial pneumonia Source: Annual Congress 2009 - Airways remodelling Year: 2009
Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010
Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007
Serum albumin and probability of pleural effusion in patients with community-acquired pneumonia Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
The influence of acute respiratory tract infection on the serum levels of KL-6 and SP-D in chronic interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006
Serum procalcitonine (PCT) as a marker of respiratory infection by pseudomonas aeruginosa (PA) in patients with COPD or bronchiectasis Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of Pneumocystis carinii pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 336s Year: 2003
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia Source: Eur Respir J 2005; 25: 688-692 Year: 2005
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008